AngioDynamics to Participate in the RBC Capital Markets 2007 Healthcare Conference
AngioDynamics to Participate in the RBC Capital Markets 2007 Healthcare Conference
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 6, 2007--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that President and CEO Eamonn Hobbs will participate in a panel discussion on "Poking Around the Cath Lab: Bringing Innovation To Cardiovascular Disease" at the 2007 RBC Capital Markets Healthcare Conference on Wednesday, December 12, 2007 at 11:00 a.m. Eastern Time in The Westin New York at Times Square in New York.Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Company's website at www.angiodynamics.com.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.
CONTACT: AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Julie Huang, 646-201-5445 (Investor Relations)
jhuang@evcgroup.com
Doug Sherk, 646-201-5445 (Investor Relations)
dsherk@evcgroup.com
Steve DiMattia, 646-201-5445 (Media)
sdimattia@evcgroup.com
SOURCE: AngioDynamics, Inc.